Novartis Wins Judgment In Mylan Heart Drug Patent Fight
A West Virginia federal judge said Mylan's proposed generic version of heart medication Entresto would infringe a pair of patents that Swiss pharmaceutical giant Novartis has on the brand-name product....To view the full article, register now.
Already a subscriber? Click here to view full article